All in all, our study not only elucidated a potential mechanism highlighting how circRNAs affect HCC progression and immune infiltration but also promulgated that circRANGAP1/ NRAS axis may be an important therapeutic target for HCC patients. The gene discussed is NRAS; the disease is hepatocellular carcinoma.